Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

ARWR Arrowhead Pharmaceuticals Inc

24,99

-0,01 (-0,04%)

Zuletzt aktualisiert: 17:49:10

Verzögert um 15 Minuten

Form 144/A - Report of proposed sale of securities: [Amend]

Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Arrowhead Pharmaceuticals Charts.

Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Arrowhead Pharmaceuticals Charts.

News Arrowhead Pharmaceuticals Inc

Form 8-K - Current report
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Turnstone Biologics Appoints William Waddill to its Board of Directors
Dienstag 16 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 6 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Dienstag 27 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 2 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 31 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 26 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 18 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Arrowhead Pharmaceuticals Inc News-Artikel

Health Care Select Sector

JP Morgan Chase

BNP Paribas (QX)

Energy Select Sector SPDR

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen